The Physiology of Glucagon
Open accessAbstract
This short review outlines the physiology of glucagon in vivo, with an emphasis on its neural control, the author's area of interest. Glucagon is secreted from alpha cells, which are a minority of the pancreatic islet. Anatomically, they are down stream from the majority islet beta cells. Beta-cell secretory products restrain glucagon secretion. Activation of the autonomic nerves, which innervate the islet, increases glucagon secretion. Glucagon is secreted into the portal vein and thus has its major physiologic action at the liver to break down glycogen. Glucagon thereby maintains hepatic glucose production during fasting and increases hepatic glucose production during stress, including the clinically important stress of hypoglycemia. Three different mechanisms proposed to stimulate glucagon secreted during hypoglycemia are discussed: (1) a stimulatory effect of low glucose directly on the alpha cell, (2) withdrawal of an inhibitory effect of adjacent beta cells, and (3) a stimulatory effect of autonomic activation. In type 1 diabetes (T1DM), increased glucagon secretion contributes to the elevated ketones and acidosis present in diabetic ketoacidosis (DKA). It also contributes to the hyperglycemia seen with or without DKA. The glucagon response to insulin-induced hypoglycemia is impaired soon after the development of T1DM. The mediators of this impairment include loss of beta cells and loss of sympathetic nerves from the autoimmune diabetic islet.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clinically, glucagon is used as a rescue drug to treat severe hypoglycemic episodes.
“Clinically, glucagon is used as a rescue drug to treat severe hypoglycemic episodes.”
From Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients (2013) · cites this paper as [2]
Impaired endogenous glucagon response increases the risk of severe hypoglycemia and requires use of exogenous glucagon injections as rescue treatment in the most severe cases.
“In T1DM patients, endogenous glucagon response to insulin-induced hypoglycemia is impaired,2 which increases the risk of severe hypoglycemia and requires use of exogenous glucagon injections as a rescue treatment in the most severe cases.”
From Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients (2013) · cites this paper as [2]
In type 1 diabetes mellitus patients, the endogenous glucagon response to insulin-induced hypoglycemia is impaired.
“In T1DM patients, endogenous glucagon response to insulin-induced hypoglycemia is impaired,2 which increases the risk of severe hypoglycemia and requires use of exogenous glucagon injections as a rescue treatment in the most severe cases.”
From Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients (2013) · cites this paper as [2]
Cites
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882 · see citing works
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7911 · Cited by 880 · see citing works
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724 · see citing works
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688 · see citing works
Essential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685 · see citing works
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531 · see citing works
Unique Arrangement of α- and β-Cells in Human Islets of Langerhans
Bosco, D., Armanet, M., Morel, P., Niclauss, N., Sgroi, A., Muller, Y. D., Giovannoni, L., Parnaud, G., & Berney, T. (2010) · Diabetes · doi:10.2337/db09-1177 · Cited by 450 · see citing works
Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes · doi:10.2337/diab.32.2.134 · Cited by 433 · see citing works
Vagal, Cholinergic Regulation of Pancreatic Polypeptide Secretion
Schwartz, T. W., Holst, J. J., Fahrenkrug, J., Jensen, S. L., Nielsen, O. V., Rehfeld, J. F., de Muckadell, O. B. S., & STADIL, F. (1978) · Journal of Clinical Investigation · doi:10.1172/jci108992 · Cited by 386 · see citing works
Borg, M. A., Sherwin, R. S., Borg, W. P., Tamborlane, W. V., & Shulman, G. I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119165 · Cited by 359 · see citing works
STUDIES ON THE CONDITIONS OF ACTIVITY IN ENDOCRINE GLANDS
Cannon, W. B., McIver, M. A., & Bliss, S. W. (1924) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1924.69.1.46 · Cited by 358 · see citing works
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351 · see citing works
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337 · see citing works
Insulin Regulation of Lipolysis in Nondiabetic and IDDM Subjects
Jensen, M. D., Caruso, M., Heiling, V. J., & Miles, J. M. (1989) · Diabetes · doi:10.2337/diab.38.12.1595 · Cited by 331 · see citing works
Schäfer, M. K.-H., Eiden, L. E., & Weihe, E. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00516-2 · Cited by 323 · see citing works
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296 · see citing works
Franklin, I., Gromada, J., Gjinovci, A., Theander, S., & Wollheim, C. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1808 · Cited by 291 · see citing works
Glucagon: molecular physiology, clinical and therapeutic implications
Lefèbvre, P. J., & Unger, R. H. (1972) · Medical Entomology and Zoology · Cited by 268 · see citing works
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.
Borg, W. P., During, M. J., Sherwin, R. S., Borg, M. A., Brines, M. L., & Shulman, G. I. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117150 · Cited by 265 · see citing works
Wendt, A., Birnir, B., Buschard, K., Gromada, J., Salehi, A. A., Sewing, S., Rorsman, P., & Braun, M. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1038 · Cited by 259 · see citing works
Cherrington, A. D., Chiasson, J. L., Liljenquist, J. E., Jennings, A. S., Keller, U., & Lacy, W. W. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108596 · Cited by 249 · see citing works
Gerich, J. E., Charles, M. A., & Grodsky, G. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107823 · Cited by 230 · see citing works
Hyperglucagonemia in diabetic ketoacidosis
Müller, W. A., Faloona, G. R., & Unger, R. H. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90083-1 · Cited by 221 · see citing works
Endocrine regulation of protein breakdown in skeletal muscle
Kettelhut, Í. D. C., Wing, S. S., & Goldberg, A. L. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040805 · Cited by 197 · see citing works
Banarer, S., McGregor, V. P., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.4.958 · Cited by 194 · see citing works
Role of Brain in Counterregulation of Insulin-Induced Hypoglycemia in Dogs
Biggers, D. W., Myers, S. R., Neal, D. W., Stinson, R. L., Cooper, N. B., Jaspan, J. B., Williams, P. E., Cherrington, A. D., & Frizzell, R. T. (1989) · Diabetes · doi:10.2337/diab.38.1.7 · Cited by 192 · see citing works
Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man.
Gerich, J., Davis, J., Lorenzi, M., Rizza, R., Bohannon, N., Karam, J., Lewis, S., Kaplan, R., Schultz, T., & Cryer, P. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.4.e380 · Cited by 183 · see citing works
Chronic hypoglycemia increases brain glucose transport
McCall, A. L., Fixman, L. B., Fleming, N., Tornheim, K., Chick, W., & Ruderman, N. B. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.4.e442 · Cited by 174 · see citing works
Davis, S. N., Shavers, C., Costa, F., & Mosqueda-Garcia, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118839 · Cited by 173 · see citing works
Schäfer, M. K.-H., Eiden, L. E., & Weihe, E. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)80196-0 · Cited by 170 · see citing works
LILJENQUIST, J. E., Mueller, G., Cherrington, A. D., Keller, U. B., Chiasson, J. L., Perry, J., LACY, W. W., & Rabinowitz, D. L. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108649 · Cited by 164 · see citing works
Stimulation of Glucagon Secretion by Epinephrine in Man
GERICH, J. E., KARAM, J. H., & FORSHAM, P. H. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-3-479 · Cited by 164 · see citing works
Raju, B., & Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.3.757 · Cited by 155 · see citing works
Fukuda, M., Tanaka, A., Tahara, Y., Ikegami, H., Yamamoto, Y., Kumahara, Y., & Shima, K. (1988) · Diabetes · doi:10.2337/diab.37.1.81 · Cited by 145 · see citing works
Bo, A.-R., Veith, R., & Taborsky, G. (1987) · Endocrinology · doi:10.1210/endo-121-1-323 · Cited by 145 · see citing works
Self-citationInsulin Reciprocally Regulates Glucagon Secretion in Humans
Cooperberg, B. A., & Cryer, P. E. (2010) · Diabetes · doi:10.2337/db10-0728 · Cited by 145 · see citing works
Glucagon Release Induced by Pancreatic Nerve Stimulation in the Dog
Marliss, E. B., Girardier, L., Seydoux, J., Wollheim, C. B., Kanazawa, Y., Orci, L., Renold, A. E., & Porte, D. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107292 · Cited by 141 · see citing works
Wang, Z., Young, L. J., Liu, Y., & Insel, T. R. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970224)378:4 · Cited by 135 · see citing works
Glucagon Secretion from the Perfused Pancreas of Streptozotocin-treated Rats
Weir, G. C., Knowlton, S. D., Atkins, R. F., McKennan, K. X., & Martin, D. B. (1976) · Diabetes · doi:10.2337/diab.25.4.275 · Cited by 122 · see citing works
The Mechanism of Vagal Nerve Stimulation of Glucagon and Insulin Secretion in the Dog*
Åhrén, B., & Taborsky, G. J. (1986) · Endocrinology · doi:10.1210/endo-118-4-1551 · Cited by 122 · see citing works
Self-citationZinc, Not Insulin, Regulates the Rat α-Cell Response to Hypoglycemia In Vivo
Zhou, H., Zhang, T., Harmon, J. S., Bryan, J., & Robertson, R. P. (2007) · Diabetes · doi:10.2337/db06-1454 · Cited by 122 · see citing works
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
Asplin, C. M., Paquette, T. L., & Palmer, J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110251 · Cited by 119 · see citing works
Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
Greenbaum, C. J., Havel, P. J., Taborsky, G. J., & Klaff, L. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115375 · Cited by 106 · see citing works
Self-citationZhou, H., Tran, P. O. T., Yang, S., Zhang, T., LeRoy, E., Oseid, E. A., & Robertson, R. P. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1482 · Cited by 99 · see citing works
Early, Selective, and Marked Loss of Sympathetic Nerves From the Islets of BioBreeder Diabetic Rats
Mei, Q., Mundinger, T. O., Lernmark, Å., & Taborsky, G. J. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2997 · Cited by 97 · see citing works
Self-citationInfluence of Insulin in the Ventromedial Hypothalamus on Pancreatic Glucagon Secretion In Vivo
Paranjape, S., Chan, O. T. M., Zhu, W., Horblitt, A. M., McNay, E. C., Cresswell, J. A., Bogan, J. S., McCrimmon, R. J., & Sherwin, R. S. (2010) · Diabetes · doi:10.2337/db10-0014 · Cited by 94 · see citing works
Havel, P. J., & Åhrén, B. (1997) · Diabetes · doi:10.2337/diab.46.5.801 · Cited by 91 · see citing works
McCrimmon, R. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27775 · Cited by 86 · see citing works
A quantitative analysis of the sensory and sympathetic innervation of the mouse pancreas
Lindsay, T. H., Halvorson, K. G., Peters, C. M., Ghilardi, J. R., Kuskowski, M. A., Wong, G. Y., & Mantyh, P. W. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.055 · Cited by 78 · see citing works
Bloom, S. R., & Edwards, A. V. (1981) · The Journal of Physiology · doi:10.1113/jphysiol.1981.sp013730 · Cited by 74 · see citing works
Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency.
Cherrington, A. D., LILJENQUIST, J. E., Shulman, G. I., Williams, P. E., & LACY, W. W. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.3.e263 · Cited by 67 · see citing works
Hypoglycemia Begets Hypoglycemia in IDDM
Cryer, P. E. (1993) · Diabetes · doi:10.2337/diab.42.12.1691 · Cited by 67 · see citing works
Bolli, G., De Feo, P., Perriello, G., De Cosmo, S., Compagnucci, P., Santeusanio, F., Brunetti, P., & Unger, R. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111315 · Cited by 64 · see citing works
Havel, P. J., Veith, R. C., Dunning, B. E., & Taborsky, G. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113763 · Cited by 61 · see citing works
Self-citationTaborsky, G. J., Mei, Q., Hackney, D. J., Figlewicz, D. P., LeBoeuf, R. C., & Mundinger, T. O. (2009) · Diabetologia · doi:10.1007/s00125-009-1494-5 · Cited by 59 · see citing works
Self-citationUnger, R. H. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630160050012 · Cited by 55 · see citing works
Rossi, J., Santamäki, P., Airaksinen, M. S., & Herzig, K.-H. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1324 · Cited by 55 · see citing works
Havel, P. J., Akpan, J. O., CURRY, D. L., Stern, J. S., Gingerich, R. L., & Åhrén, B. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.265.1.r246 · Cited by 51 · see citing works
Epinephrine Secretion, Hypoglycemia Unawareness, and Diabetic Autonomic Neuropathy
Hoeldtke, R. D., & Boden, G. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-6-199403150-00011 · Cited by 49 · see citing works
Age at Onset of Type 1 Diabetes in Parents and Recurrence Risk in Offspring
Harjutsalo, V., Lammi, N., Karvonen, M., & Groop, P. (2009) · Diabetes · doi:10.2337/db09-0344 · Cited by 46 · see citing works
Havel, P. J., Parry, S. J., Stern, J. S., Akpan, J. O., Gingerich, R. L., Taborsky, G. J., & CURRY, D. L. (1994) · Metabolism · doi:10.1016/0026-0495(94)90267-4 · Cited by 40 · see citing works
Self-citationHavel, P. J., Veith, R. C., Dunning, B. E., & Taborsky, G. J. (1991) · Diabetes · doi:10.2337/diab.40.9.1107 · Cited by 40 · see citing works
Self-citationHavel, P. J., Mundinger, T. O., & Taborsky, G. J. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.1.e20 · Cited by 40 · see citing works
Self-citationAutonomic Mediation of Glucagon Secretion During Insulin-Induced Hypoglycemia in Rhesus Monkeys
Havel, P. J., & Valverde, C. R. (1996) · Diabetes · doi:10.2337/diab.45.7.960 · Cited by 39 · see citing works
Rossetti, P., Porcellati, F., Ricci, N. B., Candeloro, P., Cioli, P., Nair, K. S., Santeusanio, F., Bolli, G. B., & Fanelli, C. G. (2008) · Diabetes · doi:10.2337/db08-0276 · Cited by 39 · see citing works
Neuropeptide Y and peptide YY immunoreactivities in the pancreas of various vertebrates.
Ding, W.-G., Kimura, H., Fujimura, M., & Fujimiya, M. (1997) · Peptides · doi:10.1016/s0196-9781(97)00237-4 · Cited by 31 · see citing works
Glycemic Actions of Alanine and Terbutaline in IDDM
Wiethop, B. V., & Cryer, P. E. (1993) · Diabetes Care · doi:10.2337/diacare.16.8.1124 · Cited by 27 · see citing works
Dunning, B. E., Scott, M. F., Neal, D. W., & Cherrington, A. D. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.5.e746 · Cited by 25 · see citing works
Wada, M., Connolly, C. C., Tarumi, C., Neal, D. W., & Cherrington, A. D. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.2.e194 · Cited by 23 · see citing works
Loss of Potentiating Effect of Hypoglycemia on the Glucagon Response to Hyperaminoacidemia in IDDM
Caprio, S., Tamborlane, W. V., Zych, K., Gerow, K., & Sherwin, R. S. (1993) · Diabetes · doi:10.2337/diab.42.4.550 · Cited by 21 · see citing works
Patel, D. G. (1984) · Metabolism · doi:10.1016/0026-0495(84)90098-2 · Cited by 19 · see citing works
Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogs
Dobbins, R. L., Davis, S. N., Neal, D. W., Caumo, A., Cobelli, C., & Cherrington, A. D. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90209-8 · Cited by 19 · see citing works
Hepatic glucagon clearance during insulin induced hypoglycemia
Herold, K., & Jaspan, J. (1986) · Hormone and Metabolic Research · doi:10.1055/s-2007-1012339 · Cited by 16 · see citing works
Tominaga, M., Maruyama, H., Vasko, M. R., Baetens, D., Orci, L., & Unger, R. H. (1987) · Diabetes · doi:10.2337/diab.36.3.365 · Cited by 16 · see citing works
Pentobarbital suppresses basal and reflexive pancreatic polypeptide release in dogs
Taborsky, G. J., Paquette, T. L., Pfeifer, M. A., & Gingerich, R. L. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.249.6.e577 · Cited by 11 · see citing works
Self-citationGlucagon Signal‐Transduction Mechanisms
Exton, J. H. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070213 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 77 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nauck, M. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12591 · Cited by 429 · see citing works
Tirosh, A., Calay, E. S., Tuncman, G., Claiborn, K. C., Inouye, K., Eguchi, K., Alcala, M., RATHAUS, M., Hollander, K. S., Ron, I., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav0120 · Cited by 297 · see citing works
Tsatsoulis, A., Mantzaris, M. D., Bellou, S., & Andrikoula, M. (2013) · Metabolism · doi:10.1016/j.metabol.2012.11.004 · Cited by 174 · see citing works
Castle, J. R., El Youssef, J., Wilson, L. M., Reddy, R., Resalat, N., Branigan, D., Ramsey, K., Leitschuh, J., Rajhbeharrysingh, U., Senf, B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0228 · Cited by 152 · see citing works
The Biology of Glucagon and the Consequences of Hyperglucagonemia
Albrechtsen, N. J. W., Kuhre, R. E., Pedersen, J., Knop, F. K., & Holst, J. J. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0090 · Cited by 124 · see citing works
Neural control of the endocrine pancreas.
Rodriguez-Diaz, R., & Caicedo, A. (2014) · Best practice & research. Clinical endocrinology & metabolism · doi:10.1016/j.beem.2014.05.002 · Cited by 76 · see citing works
Galsgaard, K. D., Winther‐Sørensen, M., Ørskov, C., Kissow, H., Poulsen, S. S., Vilstrup, H., Prehn, C. P., Adamski, J., Jepsen, S. L., Hartmann, B., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00198.2017 · Cited by 117 · see citing works
Hövelmann, U., Bysted, B. V., Mouritzen, U., Macchi, F., Lamers, D., Kronshage, B., Møller, D. V., & Heise, T. (2018) · Diabetes Care · doi:10.2337/dc17-1402 · Cited by 115 · see citing works
Central mechanisms of glucose sensing and counterregulation in defense of hypoglycemia
Stanley, S., Moheet, A., & Seaquist, E. R. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00226 · Cited by 112 · see citing works
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Maletkovic, J., & Drexler, A. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.001 · Cited by 91 · see citing works
Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus
Castellanos, L. E., Tuffaha, M., Koren, D., & Levitsky, L. L. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00397-0 · Cited by 89 · see citing works
Wolkowicz, K. L., Aiello, E. M., Vargas, E., Teymourian, H., Tehrani, F., Wang, J., Pinsker, J. E., Doyle, F. J., Patti, M., Laffel, L. M., et al. (2020) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10201 · Cited by 79 · see citing works
Bellis, A., Mauro, C., Barbato, E., Ceriello, A., Cittadini, A., & Morisco, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020775 · Cited by 61 · see citing works
Zarrin, M., Matteis, L. D., Vernay, M. C. M. B., Wellnitz, O., van Dorland, H. A., & Bruckmaier, R. M. (2013) · Journal of Dairy Science · doi:10.3168/jds.2012-6224 · Cited by 62 · see citing works
Glucagon's Metabolic Action in Health and Disease
Zeigerer, A., Sekar, R., Kleinert, M., Nason, S. R., Habegger, K. M., & Müller, T. D. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200013 · Cited by 76 · see citing works
Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use
Taleb, N., Haidar, A., Messier, V., Gingras, V., Legault, L., & RABASA-LHORET, R. P. R. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12789 · Cited by 59 · see citing works
Glucagon orchestrates stress‐induced hyperglycaemia
Harp, J. B., Yancopoulos, G. D., & Gromada, J. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12668 · Cited by 58 · see citing works
Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes
Marroquí, L., Alonso‐Magdalena, P., Merino, B., Fuentes, E., Nadal, Á., & Quesada, I. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000031 · Cited by 55 · see citing works
Ketogenic Diet: an Endocrinologist Perspective
Kuchkuntla, A. R., Shah, M., Velapati, S. R., Gershuni, V. M., Rajjo, T. I., Nanda, S., Hurt, R. T., & Mundi, M. S. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00297-x · Cited by 51 · see citing works
Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis
Dong, C. X., & Brubaker, P. L. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.185 · Cited by 43 · see citing works
The Complex Exocrine–Endocrine Relationship and Secondary Diabetes in Exocrine Pancreatic Disorders
Chen, N., Ranjit Unnikrishnan, I., Anjana, R. M., Mohan, V., & Pitchumoni, C. S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822a2ae5 · Cited by 43 · see citing works
Hypoglycaemia unawareness in patients with type 1 diabetes
Szadkowska, A., Czyżewska, K., Pietrzak, I., Mianowska, B., Jarosz-Chobot, P. A., & Myśliwiec, M. (2018) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2018.80994 · Cited by 41 · see citing works
Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte
Habegger, K. M. (2022) · Diabetes · doi:10.2337/dbi22-0002 · Cited by 40 · see citing works
Ward, W. K., Castle, J. R., & Youssef, J. E. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500608 · Cited by 36 · see citing works
Glucagon, cyclic AMP, and hepatic glucose mobilization: A half‐century of uncertainty
Rodgers, R. L. (2022) · Physiological Reports · doi:10.14814/phy2.15263 · Cited by 33 · see citing works
Kobayati, A., Haidar, A., & Tsoukas, M. A. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14637 · Cited by 36 · see citing works
Malik, S. S., Padmanabhan, D., & Hull-Meichle, R. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1269139 · Cited by 33 · see citing works
Karimi, R., Yanovich, A., Elbarbry, F., & Cleven, A. J. (2024) · Metabolites · doi:10.3390/metabo14060336 · Cited by 30 · see citing works
Glucose Metabolism in Burns—What Happens?
Bădoiu, S. C., Miricescu, D., Stănescu-Spînu, I.-I., Totan, A., Badoiu, S. E., Costagliola, M., & Greabu, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105159 · Cited by 33 · see citing works
Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes
Dadlani, V., Pinsker, J. E., Dassau, E., & Kudva, Y. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1051-z · Cited by 30 · see citing works
Postprandial dysmetabolism: Too early or too late?
Pappas, C., Kandaraki, E., Tsirona, S., Kountouras, D., Kassi, G., & Diamanti‐Kandarakis, E. (2016) · HORMONES · doi:10.14310/horm.2002.1697 · Cited by 29 · see citing works
Clinical Presentation and Diagnostic Approach to Hypoglycemia in Adults Without Diabetes Mellitus
Palani, G., Stortz, E., & Moheet, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2022.11.010 · Cited by 29 · see citing works
Hövelmann, U., Olsen, M. B., Mouritzen, U., Lamers, D., Kronshage, B., & Heise, T. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13562 · Cited by 28 · see citing works
Zulet, M. Á., Navas‐Carretero, S., y Sánchez, D. L., Abete, I., Flanagan, J., Issaly, N., Fança‐Berthon, P., Bily, A. C., Roller, M., & Martínez, J. A. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.04.027 · Cited by 27 · see citing works
Sensitization of endocrine organs to anterior pituitary hormones by the autonomic nervous system
Engeland, W. C. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00004-3 · Cited by 23 · see citing works
Disorders of the Endocrine System
Reed, S. M., Bayly, W. M., & Sellon, D. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44329-6.00016-4 · Cited by 21 · see citing works
Glucose transporters in the mammalian blood cells
Vrhovac, I., & Breljak, D. (2014) · Hrčak Portal of scientific journals of Croatia (University Computing Centre) · Cited by 20 · see citing works
A closed-loop multi-level model of glucose homeostasis
Uluseker, C., Simoni, G., Marchetti, L., Dauriz, M., Matone, A., & Priami, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190627 · Cited by 21 · see citing works
Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients
Lv, D., Breton, M. D., & Farhy, L. S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0150 · Cited by 17 · see citing works
Pancreatic Endocrine Effects of Dopamine Receptors in Human Islet Cells
Zhang, Y., Zheng, R., Meng, X., Wang, L., Liu, L., & Gao, Y. (2015) · Pancreas · doi:10.1097/mpa.0000000000000357 · Cited by 18 · see citing works
Glucagon's Metabolic Action in Health and Disease
Zeigerer, A., Sekar, R., Kleinert, M., Nason, S. R., Habegger, K. M., & Müller, T. D. (2021) · Comprehensive physiology · doi:10.1002/j.2040-4603.2021.tb00161.x · Cited by 18 · see citing works
Reed, J., Bain, S. C., & Kanamarlapudi, V. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s415934 · Cited by 18 · see citing works
Role of islet peptides in beta cell regulation and type 2 diabetes therapy.
Khan, D., Moffet, C., Flatt, P., & Kelly, C. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.014 · Cited by 15 · see citing works
Earle, M., Ault, B., & Bonney, C. (2020) · Clinical Practice and Cases in Emergency Medicine · doi:10.5811/cpcem.2020.2.45904 · Cited by 14 · see citing works
Damato, E. G., Fillioe, S. J., Margevicius, S. P., Mayes, R. S., Somogyi, J. E., Vannix, I. S., Abdollahifar, A., Turner, A. M., Ilcus, L. S., & Decker, M. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.876750 · Cited by 13 · see citing works
Bottasso, E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00632 · Cited by 13 · see citing works
Dual‐hormone treatment with insulin and glucagon in patients with type 1 diabetes
Reiband, H. K., Schmidt, S., Ranjan, A. G., Holst, J. J., Madsbad, S., & Nørgaard, K. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2632 · Cited by 12 · see citing works
Proteins: Structure, properties, and importance
Prasad, B., Shiv, A. K., Bharati, A. C., & Mallick, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91684-4.00003-7 · Cited by 11 · see citing works
Anti-inflammatory and atheroprotective properties of glucagon
Osaka, N., Kushima, H., Mori, Y., Saito, T., Hiromura, M., Terasaki, M., Yashima, H., Ohara, M., Fukui, T., Matsui, T., et al. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120965183 · Cited by 11 · see citing works
Similar Developmental Patterns of Ghrelin- and Glucagon-Expressing Cells in the Human Pancreas
Vignjević, S., Todorović, V., Damjanovic, S. S., Budeč, M., Ajtić, O. M., Djikić, D., Drndarević, N., Mićić, M., Mišković-Krivokapić, J., Djuricic, S. M., et al. (2012) · Cells Tissues Organs · doi:10.1159/000335469 · Cited by 10 · see citing works
Classical and non-classical islet peptides in the control of β-cell function
Khan, D., Moffett, R. C., Flatt, P. R., & Tarasov, A. I. (2021) · Peptides · doi:10.1016/j.peptides.2021.170715 · Cited by 10 · see citing works
Glycaemic control in end-of-life care
Lindskog, M., Kärvestedt, L., & Fürst, C. J. (2014) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000095 · Cited by 10 · see citing works
Damiano, F., Mercuri, E., Stanca, E., Gnoni, G. V., & Siculella, L. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.07.011 · Cited by 10 · see citing works
New Developments in Glucagon Treatment for Hypoglycemia
Hayward, L., & Wilson, L. M. (2022) · Drugs · doi:10.1007/s40265-022-01754-8 · Cited by 10 · see citing works
Bessho, M., Murase‐Mishiba, Y., Imagawa, A., Terasaki, J., & Hanafusa, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113254 · Cited by 9 · see citing works
Kinsella, H. M., Hostnik, L. D., Rings, L. M., Swink, J. M., Burns, T. A., & Toribio, R. E. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16024 · Cited by 8 · see citing works
Glucagonotropic and glucagonostatic effects of KATP channel closure and potassium depolarization.
Früh, E., Elgert, C., Eggert, F., Scherneck, S., & Rustenbeck, I. (2020) · Endocrinology · doi:10.1210/endocr/bqaa136 · Cited by 10 · see citing works
Bottasso, E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00633 · Cited by 8 · see citing works
Brüning, D., Morsi, M., Früh, E., Scherneck, S., & Rustenbeck, I. (2022) · Endocrinology · doi:10.1210/endocr/bqac125 · Cited by 8 · see citing works
Biomimetic Cell Membrane Layers for the Detection of Insulin and Glucagon
Nandhakumar, P., Sun, L., Li, Z., Cheung, C., Nguyen, L., Ding, S., Gao, W., Zhang, L., & Wang, J. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05347 · Cited by 7 · see citing works
Miyaji, M., Haga, S., Matsuyama, H., & Hosoda, K. (2016) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2016.06.023 · Cited by 5 · see citing works
A Survey and Guide to the Development of Fatty Acid‐derivatized Peptide Therapeutics
Jacobsen, M. T., Poulsen, C., Kopp, K. L., Olsen, J., & Cox, N. (2025) · Peptide Science · doi:10.1002/9781119824701.ch07 · Cited by 5 · see citing works
Chai, J., Sun, Z., Zhou, Q., & Xu, J. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s425156 · Cited by 4 · see citing works
Аbramova, Т. V., & Kolesnyk, Y. M. (2017) · Pathologia · doi:10.14739/2310-1237.2017.2.109249 · Cited by 4 · see citing works
Mortuza, A., Mason, L., & Mustafa, A. (2021) · Aquaculture Research · doi:10.1111/are.15407 · Cited by 4 · see citing works
Discovery of novel OXM-based glucagon-like peptide 1 (GLP-1)/glucagon receptor dual agonists
Zhang, X., Cai, Y., Yao, Z., Chi, H., Li, Y., Shi, J., Zhou, Z., & Sun, L. (2023) · Peptides · doi:10.1016/j.peptides.2023.170948 · Cited by 4 · see citing works
Falla autonómica asociada a hipoglucemia
Houssay, S., Recalde, M., Rey, M. G., García, C., Urdaneta, R., Huber, F., Flores, C. L. U., Domínguez, C., & Nader, E. (2021) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v55i2.473 · Cited by 4 · see citing works
NEURAL CONTROL OF PANCREATIC PEPTIDE HORMONE SECRETION.
Verberne, A., & Mussa, B. M. (2022) · Peptides · doi:10.1016/j.peptides.2022.170768 · Cited by 4 · see citing works
Diabetic Ketoacidosis in adults: Part 1. Pathogenesis and diagnosis
Azkoul, A., Sim, S. Y., & Lawrence, V. (2022) · South Sudan Medical Journal · doi:10.4314/ssmj.v15i2.6 · Cited by 4 · see citing works
Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications
Goudra, B., Merli, G. J., & Green, M. S. (2024) · Pharmaceuticals · doi:10.3390/ph18010004 · Cited by 3 · see citing works
Mortuza, A., Fahim, N. F., Ahmed, M., & Mustafa, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290835 · Cited by 3 · see citing works
A Guide to the Postmortem Investigation of Starvation in Adults
Garland, J., & Irvine, R. (2022) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000763 · Cited by 3 · see citing works
Mumu, S. K., & Mustafa, A. (2022) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2022.2080558 · Cited by 3 · see citing works
Dholariya, S. J., Parchwani, D. N., Dutta, S., & Singh, R. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2138343 · Cited by 2 · see citing works
Lim, J. J., Sequeira, I. R., Yip, W. C. Y., Lu, L. W., Miles-Chan, J. L., & Poppitt, S. D. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111084 · Cited by 2 · see citing works
Incretins for management of obesity and obstructive sleep apnea
Hu, X., Yee, B. J., Phillips, C. L., Chapman, J. L., & Grunstein, R. R. (2025) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2025.2513516 · Cited by 2 · see citing works
In insulin-treated type 1 diabetes, canagliflozin increased diabetic ketoacidosis
Sfeir, J. G., & Montori, V. M. (2016) · Annals of Internal Medicine · doi:10.7326/acpjc-2016-165-2-002 · Cited by 2 · see citing works
Robyn, J., Plancke, L., Boshuizen, B., meeûs, C. D., Bruijn, M. D., & Delesalle, C. J. G. (2017) · Vlaams Diergeneeskundig Tijdschrift · doi:10.21825/vdt.v86i5.16166 · Cited by 2 · see citing works
G-protein tonic inhibition of calcium channels in pancreatic β-cells
Quiroz‐Acosta, T., Bermeo, K., Arenas, I., & Garcı́a, D. E. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00447.2022 · Cited by 2 · see citing works
Hormones and Growth Factors Used Therapeutically
Walsh, G. (2015) · doi:10.1002/9781119117599.ch8 · Cited by 2 · see citing works
Deguchi, M., Hosoda, A., Fukumura, T., Saeki, S., & Kim, D.-H. (2025) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbaf133 · Cited by 1 · see citing works
Sayed, H. Y. I. A., Abdelglil, M. I., Mohamed, H. R. H., Baiomy, A. A. A., & Mohamed, A. S. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103423 · Cited by 1 · see citing works
Assali, E. A., Taha, M., Salhab, A., Amer, J., Krishnan, K. C., Kostić, M., Veliova, M., Brownstein, A. J., Shirihai, O. S., Safadi, R., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102433 · Cited by 1 · see citing works
Role of glucagon in treating diabetes: Evidence and concepts (胰高血糖素在糖尿病治疗中的作用:证据与概念)
Bloomgarden, Z. T. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12107 · Cited by 1 · see citing works
Severe Trichotillomania: An Unusual Trigger of Recurrent Diabetic Ketoacidosis
Check, L., Figueroa, G. E., Galindo, L., PHAM, J., & Sherertz, R. J. (2022) · Cureus · doi:10.7759/cureus.21384 · Cited by 1 · see citing works
Diabetes in the Critically Ill Patient: DKA, HHS, and Beyond
Singh, B., Chlebek, S., & Krikorian, A. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_5 · Cited by 1 · see citing works
CaMKKbeta/AMPK Negatively Regulates Adiposity
Peng, I. (2011) · eScholarship (California Digital Library)
Examining the Role of Endoplasmic Reticulum Stress in Pancreatic Beta-cell Biology
Teodoro, T. (2012) · TSpace (University of Toronto)
The Physiological Glucagon Receptor in Rat Heart
Agostinucci, K. J. (2017) · doi:10.23860/thesis-agostinucci-kevin-2017
Sympathetic Voltage-Independent Regulation of Voltage- Gated Calcium Channels in Pancreatic β-Cells
Garcı́a, D. E. (2018) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/5/1/00194
A dynamical model and bifurcation analysis for glucagon and glucose regulatory system
Mohabati, F., Molaei, M. R., & Waezizadeh, T. (2019) · Journal of Information and Optimization Sciences · doi:10.1080/02522667.2019.1630937
Dasiglucagon for treating severe hypoglycemia in patients with diabetes
Ju, Y., Zhang, D., & Yang, J. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2103537
Miért nem fenyegeti a ketoacidosis a teljes hasnyálmirigy-eltávolításon átesett betegeket?
Kaszoni-Bokor, G. L., Kis, J. T., Szemán, A., Kiss, K. A., Polyák, A., Czégeni, A., Hosszúfalusi, N., Schandl, L., & Winkler, G. (2025) · Orvosi Hetilap · doi:10.1556/650.2025.33407
Winther‐Sørensen, M., Rasmussen, C. B., Trammell, S. A. J., Hansen, C., Vyberg, M., Serizawa, R., Richter, E. A., Grevengoed, T. J., Gluud, L. L., Kuhre, R. E., et al. (2025) · Peptides · doi:10.1016/j.peptides.2025.171462 · Cited by 2 · see citing works
Control Systems in the Living World
Cabej, N. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-401667-5.00001-8
- Authors
- Taborsky, G. J.
- Affiliations
- VA Puget Sound Health Care System (US)
- Corresponding author
- Taborsky, Gerald J.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2010-11
- Volume
- 4
- Issue
- 6
- Pages
- 1338-1344
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC3005043
- OpenAlex
- W2131867652
- Cited by
- 96
- References
- 77
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 14 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 4
- Type
- conference abstract
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050154)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- glucagon, glucagon secretion, alpha cells, pancreatic beta cells, hepatic glucose production, glycogenolysis, hypoglycemia, type 1 diabetes, diabetic ketoacidosis, insulin-induced hypoglycemia, beta cell destruction, islet autoimmunity
- MeSH terms
- Animals, Autonomic Nervous System, Blood Glucose, Diabetes Mellitus, Type 1, Glucagon, Glycogen, Homeostasis, Humans, Hypoglycemia, Insulin, Islets of Langerhans, Liver, Glucagon-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review